
Company valuation, historical trends, and peer comparisons.
According to Revolution Medicines, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 40.30B. This represents a change of 95.92% compared to the average of 20.57B of the last 4 quarters.
The mean historical Enterprise Value of Revolution Medicines, Inc. over the last ten years is 3.75B. The current 40.30B Enterprise Value has changed 975.28% with respect to the historical average. Over the past ten years (40 quarters), RVMD's Enterprise Value was at its highest in in the June 2026 quarter at 39.32B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
3.75B
Median
1.82B
Minimum
984.63M
Maximum
14.92B
Discovering the peaks and valleys of Revolution Medicines, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 162.79%
Maximum Annual Enterprise Value = 14.92B
Minimum Annual Increase = -30.19%
Minimum Annual Enterprise Value = 984.63M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 14.92B | 115.29% |
| 2024 | 6.93B | 162.79% |
| 2023 | 2.64B | 44.62% |
| 2022 | 1.82B | 1.82% |
| 2021 | 1.79B | -30.19% |
| 2020 | 2.57B | 147.26% |
| 2019 | 1.04B | 5.36% |
| 2018 | 984.63M | -5.78% |
The current Enterprise Value of Revolution Medicines, Inc. (RVMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.16B
5-year avg
5.62B
10-year avg
3.75B
Revolution Medicines, Inc.’s Enterprise Value is greater than Verastem, Inc. (815.14M), greater than Erasca, Inc. (4.86B), greater than IDEAYA Biosciences, Inc. (2.77B), greater than Tango Therapeutics, Inc. (3.42B), greater than Nurix Therapeutics, Inc. (2.15B), greater than ORIC Pharmaceuticals, Inc. (903.90M), greater than Relay Therapeutics, Inc. (3.73B), greater than Black Diamond Therapeutics, Inc. (101.21M), greater than Monte Rosa Therapeutics, Inc. (845.38M), greater than Enliven Therapeutics, Inc. (3.06B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 815.14M | $867.16M | |
| 4.86B | $4.86B | |
| 2.77B | $3.01B | |
| 3.42B | $3.74B | |
| 2.15B | $2.80B | |
| 903.90M | $938.06M | |
| 3.73B | $3.82B | |
| 101.21M | $103.43M | |
| 845.38M | $897.50M | |
| 3.06B | $3.20B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revolution Medicines, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Revolution Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Revolution Medicines, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Revolution Medicines, Inc. (RVMD)?
What is the 3-year average Enterprise Value for Revolution Medicines, Inc. (RVMD)?
What is the 5-year average Enterprise Value for Revolution Medicines, Inc. (RVMD)?
How does the current Enterprise Value for Revolution Medicines, Inc. (RVMD) compare to its historical average?